the number of canadians diagnosed with or dying from cancer will remain at “high levels” in 2026, and while survival rates are improving for several cancers, worrying trends are emerging for others, according to a new report.
overall, the projected estimates “underscore the substantial impact cancer will continue to pose in canada” in 2026, researchers report in this week’s issue of the canadian medical association journal.
nearly half the population, 42 per cent of all people in canada, is expected to be diagnosed with cancer at some point in their lives, the authors report.
an estimated 254,100 people will be diagnosed with cancer and 87,900 will die from cancer in 2026 alone.
here are five key trends to know.
pancreatic cancer is increasing and projected to be third leading cause of cancer deaths
lung, breast, prostate and colorectal cancer are expected to remain the most diagnosed cancers, accounting for nearly half (47 per cent) of all new cases diagnosed this year.
pancreatic cancer is expected to be the third most common cancer killer, behind lung and colorectal cancer.
“since the early 2000s, the incidence of pancreatic cancer has been moderately increasing while no progress has been made in reducing mortality rates,” the researchers report.
“pancreatic cancer is expected to remain the third leading cause of cancer-related death in 2026, with a similar number of males (3,400) and females (3,100) expected to die from the disease.”
excess body size has been linked to a higher risk of pancreatic cancer. according to statistics canada, 49 per cent of adults in canada have a waist circumference — and abdominal fatness — that hikes their risk for pancreatic and other cancers.
new cases of colorectal cancer are declining
overall, incidence and death rates for colorectal cancer — one of the most common cancers among both women and men — continue to fall, likely due to increased screening efforts (colonoscopies and stool sample testing) that began in the early 2000s. since then, the incidence rates have dropped by 32 per cent in men and 29 per cent in women owing to “the removal of pre-cancer lesions and earlier diagnoses” as well as improved treatments, the team reports.